fda tirzepatide compound update Says Shortage of GLP-1 Is Over FDA says 'no clinical need'

This allows the medication to be absorbed slowly and evenly into the bloodstream over time

Sexual activity remains one of the strongest risk factors for UTIs in women, and this risk does not change during semaglutide treatment

Their work reveals the role of a transporter protein named SLC33A1 in shuttling oxidized glutathione (GSSG) across the ER membrane, a process vital for sustaining the oxidative environment necessary for correct protein folding

No final FDA action has occurred as of early August 2026, so the timeline for any Category 1 placement remains uncertain and depends on internal agency review, potential public comment, and broader peptide policy under the current administration

My team of providers and I echo the sentiment of many health care providers and do not prescribe compounded semaglutide for patients, since we cannot be sure what ingredients are in compounded semaglutides or how the agents work compared to the original drugs

This helps to prevent gastrointestinal side effects like nausea and constipation